Incidence of transient and chronic hypoparathyroidism after total thyroidectomy - the experience of a tertiary center.

PTH hypocalcemia iatrogenic hypoparathyroidism malignancy total thyroidectomy

Journal

Archive of clinical cases
ISSN: 2360-6975
Titre abrégé: Arch Clin Cases
Pays: Romania
ID NLM: 101727313

Informations de publication

Date de publication:
2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: epublish

Résumé

The most common cause of hypoparathyroidism (hypoPT) in adults is iatrogenic due to total thyroidectomy, while the ideal moment for considering it chronic is still under debate. Our study aims at reporting the prevalence of transient and permanent hypoPT following thyroid surgery in a tertiary surgical center, as well as serum Parathormone (PTH) variation up to 12 months after surgery stratified according to the type of thyroid disease. 519 patients who underwent total thyroidectomy in a tertiary surgical center from 2018 to 2023 were analyzed. Postoperative hypoPT was defined as low PTH (less than 15 pg/ml) and/or hypocalcemia (albumin-corrected levels less than 8.5 mg/dl) on day 1 after surgery. Patients were considered to have permanent hypoPT if they had not recovered completely within 1 year after total thyroidectomy. PTH levels were compared according to the underlying thyroid disease. 140 patients (26.97%) had postoperative hypoPT. Twenty-two patients (4.23%) were considered to have permanent hypoPT 12 months after surgery. Approximately half of the patients recovered between 3 months and 12 months after surgery. HypoPT thyroiditis patients had higher PTH levels 3 months after surgery compared to papillary/follicular cancer and multinodular goiter, respectively, and all recovered 1 year after surgery. Papillary/follicular carcinoma was associated with a 29.4% rate of transient and 8.5% rate of chronic hypoPT, respectively. Most patients without incidental parathyroidectomy that still develop postoperative hypoPT will eventually recover; nevertheless, it can take up to 1 year for full resolution. Measuring serum PTH 3 months postoperative may be of interest.

Sections du résumé

BACKGROUND BACKGROUND
The most common cause of hypoparathyroidism (hypoPT) in adults is iatrogenic due to total thyroidectomy, while the ideal moment for considering it chronic is still under debate. Our study aims at reporting the prevalence of transient and permanent hypoPT following thyroid surgery in a tertiary surgical center, as well as serum Parathormone (PTH) variation up to 12 months after surgery stratified according to the type of thyroid disease.
MATERIAL AND METHODS METHODS
519 patients who underwent total thyroidectomy in a tertiary surgical center from 2018 to 2023 were analyzed. Postoperative hypoPT was defined as low PTH (less than 15 pg/ml) and/or hypocalcemia (albumin-corrected levels less than 8.5 mg/dl) on day 1 after surgery. Patients were considered to have permanent hypoPT if they had not recovered completely within 1 year after total thyroidectomy. PTH levels were compared according to the underlying thyroid disease.
RESULTS RESULTS
140 patients (26.97%) had postoperative hypoPT. Twenty-two patients (4.23%) were considered to have permanent hypoPT 12 months after surgery. Approximately half of the patients recovered between 3 months and 12 months after surgery. HypoPT thyroiditis patients had higher PTH levels 3 months after surgery compared to papillary/follicular cancer and multinodular goiter, respectively, and all recovered 1 year after surgery. Papillary/follicular carcinoma was associated with a 29.4% rate of transient and 8.5% rate of chronic hypoPT, respectively.
CONCLUSION CONCLUSIONS
Most patients without incidental parathyroidectomy that still develop postoperative hypoPT will eventually recover; nevertheless, it can take up to 1 year for full resolution. Measuring serum PTH 3 months postoperative may be of interest.

Identifiants

pubmed: 39479258
doi: 10.22551/2024.44.1103.10296
pmc: PMC11520184
doi:

Types de publication

Journal Article

Langues

eng

Pagination

93-97

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Cristian Velicescu (C)

Surgery Department, "Sf. Spiridon" Emergency Hospital, Iasi, Romania.
"Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Stefana Catalina Bilha (SC)

"Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Endocrinology Department, "Sf. Spiridon" Emergency Hospital, Iasi, Romania.

Alexandra Teleman (A)

Surgery Department, "Sf. Spiridon" Emergency Hospital, Iasi, Romania.
"Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Andrada Vitelariu (A)

Surgery Department, "Sf. Spiridon" Emergency Hospital, Iasi, Romania.
"Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.

Laura Teodoriu (L)

Endocrinology Department, Regional Institute of Oncology, Iasi, Romania.

Alexandru Florescu (A)

"Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Endocrinology Department, "Sf. Spiridon" Emergency Hospital, Iasi, Romania.

Roxana Novac (R)

Endocrinology Department, Moineşti Emergency Hospital, 605400 Moineşti, Romania.

Classifications MeSH